DX-895 is a synthetic analogue of camptothecin. It will be administered to patients with refractory solid tumors as a continuous infusion initially for five days with increase to 10 days, 15 days and 21 days and then with dose escalation to maximum tolerated dose over 21 days.
Showing the most recent 10 out of 600 publications